260 related articles for article (PubMed ID: 23336527)
1. Intravesical drug delivery for dysfunctional bladder.
Hsu CC; Chuang YC; Chancellor MB
Int J Urol; 2013 Jun; 20(6):552-62. PubMed ID: 23336527
[TBL] [Abstract][Full Text] [Related]
2. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction.
Janicki JJ; Chancellor MB; Kaufman J; Gruber MA; Chancellor DD
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999210
[TBL] [Abstract][Full Text] [Related]
3. Intravesical liposome therapy for interstitial cystitis.
Tyagi P; Kashyap M; Majima T; Kawamorita N; Yoshizawa T; Yoshimura N
Int J Urol; 2017 Apr; 24(4):262-271. PubMed ID: 28258657
[TBL] [Abstract][Full Text] [Related]
4. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome: Systematic Review and Meta-analysis.
Lee HY; Doo SW; Yang WJ; Song YS; Sun HY; Nho EJ; Lee B; Kim JH
Urology; 2019 Mar; 125():50-57. PubMed ID: 30552935
[TBL] [Abstract][Full Text] [Related]
6. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
Chuang YC; Lee WC; Lee WC; Chiang PH
J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
[TBL] [Abstract][Full Text] [Related]
7. Editorial comment from Dr Funahashi to intravesical drug delivery for dysfunctional bladder.
Funahashi Y
Int J Urol; 2013 Jun; 20(6):562-3. PubMed ID: 23360329
[No Abstract] [Full Text] [Related]
8. Editorial comment from Dr Saito and Dr Shimizu to intravesical drug delivery for dysfunctional bladder.
Saito M; Shimizu S
Int J Urol; 2013 Jun; 20(6):563. PubMed ID: 23360355
[No Abstract] [Full Text] [Related]
9. Advances in intravesical therapy for urinary tract disorders.
Tyagi P; Kashyap M; Hensley H; Yoshimura N
Expert Opin Drug Deliv; 2016; 13(1):71-84. PubMed ID: 26479968
[TBL] [Abstract][Full Text] [Related]
10. Intravesical electromotive drug administration technique: preliminary results and side effects.
Riedl CR; Knoll M; Plas E; Pflüger H
J Urol; 1998 Jun; 159(6):1851-6. PubMed ID: 9598474
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in intravesical drug/gene delivery.
Tyagi P; Wu PC; Chancellor M; Yoshimura N; Huang L
Mol Pharm; 2006; 3(4):369-79. PubMed ID: 16889430
[TBL] [Abstract][Full Text] [Related]
12. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
[TBL] [Abstract][Full Text] [Related]
13. State of the art in intravesical therapy for lower urinary tract symptoms.
Kaufman J; Tyagi V; Anthony M; Chancellor MB; Tyagi P
Rev Urol; 2010; 12(4):e181-9. PubMed ID: 21234261
[TBL] [Abstract][Full Text] [Related]
14. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review.
Toft BR; Nordling J
Curr Opin Urol; 2006 Jul; 16(4):268-72. PubMed ID: 16770126
[TBL] [Abstract][Full Text] [Related]
15. Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure.
Nirmal J; Tyagi P; Chancellor MB; Kaufman J; Anthony M; Chancellor DD; Chen YT; Chuang YC
J Urol; 2013 Apr; 189(4):1553-8. PubMed ID: 23127767
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the effects of instillation volume on intravesical delivery using biphasic solute transport in a deformable geometry.
Smith SG; Griffith BE; Zaharoff DA
Math Med Biol; 2019 Jun; 36(2):139-156. PubMed ID: 29659860
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
Jhang JF; Jiang YH; Kuo HC
Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive device for intravesical instillation by urological syringe adapter (MID-ii U.S.A.) for catheter-free instillation therapy of the bladder in interstitial cystitis/bladder pain syndrome.
Lovasz S
Int J Urol; 2019 Jun; 26 Suppl 1():57-60. PubMed ID: 31144753
[TBL] [Abstract][Full Text] [Related]
19. Local drug delivery to bladder using technology innovations.
Tyagi P; Tyagi S; Kaufman J; Huang L; de Miguel F
Urol Clin North Am; 2006 Nov; 33(4):519-30, x. PubMed ID: 17011388
[TBL] [Abstract][Full Text] [Related]
20. Novel Therapy with Intravesical Liposomes for Ulcerative Interstitial Cystitis/Painful Bladder Syndrome.
Peters KM; Hasenau DL; Anthony M; Kaufman J; Killinger KA
Low Urin Tract Symptoms; 2012 Jan; 4(1):51-3. PubMed ID: 26676460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
